Cargando…

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

BACKGROUND: To investigate the hypothesis that MRI derived diffusion-weighted imaging (DWI) and perfusion (MRP) parameters are sensitive image biomarkers for monitoring early antiangiogenic effects and predicting progression free survival (PFS) in advanced hepatocellular carcinoma (HCC). METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahani, Dushyant V, Jiang, Tao, Hayano, Koichi, Duda, Dan G, Catalano, Onofrio A, Ancukiewicz, Marek, Jain, Rakesh K, Zhu, Andrew X
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722053/ https://www.ncbi.nlm.nih.gov/pubmed/23842041 http://dx.doi.org/10.1186/1756-8722-6-51

Ejemplares similares

Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy
por: Lee, Sang Ho, et al.
Publicado: (2015)

Imaging for assessment of treatment response in hepatocellular carcinoma: Current update
por: Hayano, Koichi, et al.
Publicado: (2015)

Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
por: Duda, Dan G., et al.
Publicado: (2020)

Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)
por: Raut, Chandrajit P., et al.
Publicado: (2012)

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib
por: Harmon, Charles S, et al.
Publicado: (2011)

Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion
por: Hayano, Koichi, et al.
Publicado: (2013)

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
por: Zurita, A J, et al.
Publicado: (2015)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib
por: Jiménez-Fonseca, Paula, et al.
Publicado: (2018)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker
por: Ait‐Oudhia, S, et al.
Publicado: (2016)

Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation
por: Kuo, Angera H, et al.
Publicado: (2015)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma
por: Harmon, Charles S., et al.
Publicado: (2013)

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
por: DePrimo, Samuel E, et al.
Publicado: (2007)

Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation
por: Huang, Kun, et al.
Publicado: (2019)

Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2013)

Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma
por: Voss, Martin H, et al.
Publicado: (2016)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
por: Rini, Brian I., et al.
Publicado: (2011)

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
por: Donskov, Frede, et al.
Publicado: (2015)

Functional magnetic resonance: biomarkers of response in breast cancer
por: O'Flynn, Elizabeth AM, et al.
Publicado: (2011)

Advanced magnetic resonance imaging biomarkers of cerebral metastases
por: Mills, S.J., et al.
Publicado: (2012)

Magnetic Resonance Imaging Biomarkers of Punding in Parkinson’s Disease
por: Mao, Chenglu, et al.
Publicado: (2023)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: Chen, Tingsong
Publicado: (2022)

Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018)

Correction: Functional magnetic resonance: biomarkers of response in breast cancer
por: O'Flynn, Elizabeth AM, et al.
Publicado: (2011)

Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma
por: Wu, Yan, et al.
Publicado: (2015)

Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy
por: Mankodi, Ami, et al.
Publicado: (2017)

Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases
por: Kamagata, Koji, et al.
Publicado: (2021)

Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach
por: Awan, Faryal Mehwish, et al.
Publicado: (2015)

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
por: Van Hees, Stijn, et al.
Publicado: (2016)

Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
por: Block, Timothy, et al.
Publicado: (2022)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

Biomarkers and the Fontan Circulation
por: Schumacher, Kurt R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ameetjhqri2pi95ctrhfk8alnn